Funds and ETFs Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.
Equities
1349
CNE1000000W4
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.79 HKD | +0.56% |
|
-1.10% | -29.80% |
21/06 | Fudan Zhangjiang Bio-Pharmaceutical Enrolls First Patient for Glioma Drug Trial | MT |
21/06 | Shanghai Fudan Zhangjiang Bio-Pharmaceutical Terminates Libod Marketing Agreement | MT |
ETFs positioned on Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 32 M€ | +4.52% | - |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-29.80% | 70Cr | |
+7.39% | 7.21TCr | |
+15.93% | 904.53Cr | |
-22.81% | 440.44Cr | |
+17.59% | 439.23Cr | |
+25.93% | 393.64Cr | |
+4.64% | 210Cr | |
+9.09% | 197.11Cr | |
-36.86% | 187.45Cr | |
-0.50% | 164.41Cr |
- Stock Market
- Equities
- 1349 Stock
- Funds and ETFs Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.